Form 8-K GILEAD SCIENCES INC For: Jul 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Six dead in 'stampede-like' incident at India temple, ANI says
Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance
July 26, 2017 4:05 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $2.56, $0.41 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.14 billion versus the consensus estimate of $6.35 billion.
GUIDANCE:
Gilead Sciences sees FY2017 revenue of $24-25.5 billion, versus the consensus of $24.8... More

